This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sanz J, Montesinos P, Saavedra S, Lorenzo I, Senent L, Planelles D et al. Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia. Biol Blood Marrow Transplant 2010; 16: 1589–1595.
Ribera JM, Oriol A, Bethencourt C, Parody R, Hernández-Rivas JM, Moreno et al. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial. Haematologica 2005; 90: 1346–1356.
Robin M, Sanz GF, Ionescu I, Rio B, Sirvent A, Renaud M et al. Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT. Leukemia 2011; 25: 75–81.
Rénard C, Barlogis V, Mialou V, Galambrun C, Bernoux D, Goutagny MP et al. Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children. Br J Haematol 2011; 152: 322–330.
Ishikawa F, Livingston AG, Minamiguchi H, Wingard JR, Ogawa M . Human cord blood long term engrafting cells are CD34+ CD38−. Leukemia 2003; 17: 960–964.
Jerez A, Osma M, Castilla-Llorente C, Bernal A, Palacios S, Heras I et al. Transient bone marrow lymphoproliferation after umbilical cord blood transplantation: in adult exacerbated reconstitution of B cell ontogeny. Am J Hematol 2011 (e-pub ahead of print; doi:10.1002/ajh.22013).
Sanchez J, Serrano J, Gomez P, Martínez F, Martín C, Madero L et al. Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation. Br J Hematol 2002; 116: 686–694.
Reid AG, De Melo VA, Elderfield K, Clark I, Marin D, Apperley J et al. Phenotype of blasts in chronic myeloid leukemia in blastic phase-analysis of bone marrow trephine biopsies and correlation with cytogenetics. Leuk Res 2009; 33: 418–425.
Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108: 2874–2880.
Ram R, Ben-Bassat I, Shpilberg O, Polliack A, Raanani P . The late adverse events of rituximab therapy--rare but there. Leuk Lymphoma 2009; 50: 1083–1095.
Acknowledgements
The authors would like to acknowledge Dr Miguel Ortin for his critical review of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Barba, P., Garcia-Cadenas, I., Nomdedéu, J. et al. Rituximab treatment may disturb the normal pattern of lymphopoiesis after cord blood SCT. Bone Marrow Transplant 47, 458–460 (2012). https://doi.org/10.1038/bmt.2011.98
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2011.98